Categories: Business

NYSE Content Advisory: Pre-Market update + Fed Decision on deck

NEW YORK, June 18, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on June 18th

- Advertisement -
  • Stocks are fractionally higher Wednesday morning as traders continue to monitor conflict in the Middle East. Major averages ended Tuesday’s session lower while the price of crude oil rose by 4%
  • According to NBC News, President Trump is weighing options on Iran, including whether to launch a military strike. The President weighed in on Truth Social demanding “unconditional surrender.”
  • Traders are paying close attention to this afternoon’s Fed Decision, due at 2 PM ET. Economists believe it is a near-certainty that rates remain unchanged. What’s uncertain is the guidance Chair Powell will provide in his subsequent remarks.

Opening Bell
Allied Gold (NYSE: AAUC) celebrates their recent listing on the New York Stock Exchange

- Advertisement -

Closing Bell
NCPERS celebrates the close of Chief Officers Summit 25

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2713979/NYSE_Market_Update_June_18.mp4
Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–fed-decision-on-deck-302485200.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

3 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago